Fort Worth, TX (PRWEB) June 13, 2011
“A new study, using estrogen-fighting drugs, helps prevent breast cancer in high risk patients—with fewer side effects,” said Dr. Robyn Young, a specialist focusing entirely on breast cancer treatment (http://www.thecentertx.com/physicians_young.html).
Young explained, “Estrogen is a hormone that causes some types of breast cancer cells to grow. These drugs, also called aromatase inhibitors, remove estrogen. Compared to the existing prevention therapy, Tamoxifen, which slightly increases the chance of blood clots or endometrial cancer, these drugs look like a much better option for patients with a high risk of getting breast cancer.”
The new study, announced this week at the annual meeting of the American Society of Clinical Oncology, showed that aromatase inhibitors cut the relative risk of getting breast cancer by 65%, for women who had at least one risk factor—without the traditional side effects. The study was led by Dr. Paul Goss of Massachusetts General Hospital and involved 4,560 women.
This therapy is not intended to prevent the disease in those with an average risk.
High risk factors include, but are not limited to:
- Family history of breast cancer
- Breast biopsy results showing abnormal cells called hyperplasia
- Genetic testing results showing possible future breast cancer
Robyn Young, M.D. is a board certified cancer specialist focusing entirely on breast cancer treatment, with The Center for Cancer & Blood Disorders in Fort Worth, http://www.thecentertx.com. The Center offers eighteen physicians, providing cancer treatment to more than 6,000 patients annually, at ten locations: Fort Worth (three sites), Arlington, Weatherford, Burleson, Cleburne, Mineral Wells, Granbury, and Stephenville.
# # #